|[June 27, 2014]
Research and Markets: Global Companion Diagnostic Technologies Market (Indication and Geography) - Forecast to 2020
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/k23w79/global_companion)
has announced the addition of the "Global
Companion Diagnostic Technologies Market (Indication and Geography) -
Size, Share, Global Trends, Company Profiles, Demand, Insights,
Analysis, Research, Report, Opportunities, Segmentation and Forecast,
2013 - 2020" report to their offering.
Companion diagnostics are in-vitro diagnostics that provide information
about therapeutic responses of patients for a specific treatment.
Companion diagnostics market is still nascent, and it is projected to
reach $3.5 billion by 2020 from a base value of $1.1 billion in 2013,
growing at a CAGR of 20% during 2014 to 2020. The global companion
diagnostic market is segmented based on indication, technology and
geography (North America,Europe, Asia Pacific and LAMEA).
Geographically, LAMEA is the fastest growing region. The key drivers for
this market are the increase in the discovery of biomarkers and
co-development of drug and corresponding diagnostic. However, cost
associated with developing drugs could impede the growth of this market.
Opportunities for this market lie in developing companion diagnostics
for various central nervous system conditions and hereditary conditions.
Companion Diagnostics Indication Market Analysis
Companion diagnostics is segmented on the basis of its use for
indications such as oncology, cardiovascular conditions, central nervous
system indications, inflammation and virology. Oncology is the highest
revenue generating segment, as majority of the companion diagnostics
have been developed for detection of various cancer biomarkers. The key
driver for this market is an increase in research and development of
targeted drugs, which require a corresponding companion diagnostic.
Key Topics Covered:
CHAPTER 1. INTRODUCTION
CHAPTER 2. EXECUTIVE SUMMARY
CHAPTER 3. MARKET OVERVIEW
CHAPTER 4. GLOBAL COMPANION DIAGNOSTIC MARKET BY INDICATIONS
CHAPTER 5. GLOBAL COMPANION DIAGNOSTIC MARKET BY TECHNOLOGY
CHAPTER 6. GLOBAL COMPANION DIAGNOSTICS BY GEOGRAPHY
CHAPTER 7. COMPANY PROFILES
Dako (Agilent (News - Alert) Technologies)
Resonance Health Ltd
Ventana Medical Systems
For more information visit http://www.researchandmarkets.com/research/k23w79/global_companion
[ Back To TMCnet.com's Homepage ]